GPD1 and metabolic dysfunction-associated steatotic liver disease: Combined with previous studies and our analysis, we believe that GPD1 may act as a “metabolic‐immune” intersection in NAFLD and CAD by regulating lipid metabolism reprogramming of macrophages.